What Boehringer Ingelheim Pharmaceuticals, Inc. pays H-1B Scientists
Boehringer Ingelheim Pharmaceuticals, Inc. filed 10 certified H-1B LCAs for Scientist roles in FY2025-FY2026. In FY2026 (October to June), the middle half of its 5 filings stated $140,500 to $145,000 a year, with a median of $142,000.
Median, FY2026 so far$142,000
Middle half$140,500 to $145,000
Certified LCAs, FY2025-FY202610
By fiscal year
| Year | LCAs | Median | Middle half | Lowest to highest | Prevailing wage |
|---|---|---|---|---|---|
| FY2026 so far | 5 | $142,000 | $140,500 to $145,000 | $86,520 to $172,095 | $120,224 |
| FY2025 | 5 | $142,000 | $106,850 to $145,000 | $84,000 to $183,475 | $106,850 |
Prevailing wage is the median of the DOL prevailing wage on the same filings: the floor the law sets for that job and place.
By prevailing-wage level
| Level | LCAs | Median | Middle half |
|---|---|---|---|
| Level I (entry) | 1 | $84,000 | too few |
| Level II (qualified) | 4 | $143,500 | $133,213 to $145,000 |
| Level III (experienced) | 2 | $129,308 | too few |
| Level IV (fully competent) | 3 | $142,000 | too few |
Level I is entry and Level IV is fully competent, as the employer classified the position. Seniority words in the job title are folded into one title here; the level is where seniority shows.
By worksite
| Worksite | LCAs | Median | Lowest to highest |
|---|---|---|---|
| Ridgefield, CT | 8 | $143,500 | $86,520 to $183,475 |
Titles grouped here
- Senior Scientist (5)
- Scientist II (2)
- Principal Scientist (2)
- Scientist III (1)
Filed as Medical Scientists, Except Epidemiologists (SOC 19-1042).
Applying to Boehringer Ingelheim Pharmaceuticals, Inc.?
Nyanza puts these filings next to any Scientist posting you check, so you know what the employer has stated before the first call.